These multifunctional linear and macrocyclic peptides differ from the products already on the market, providing access to a new chemical space and new intellectual property Oxeltis, a medicinal chemistry and (...)
Oxeltis ranked one of the fastest growing companies in the 2015 Deloitte In Extenso Technology Fast 50 Secured 30th position after a 559% revenue growth between 2011 and 2014, expects (...)
Oxeltis is participating to RARE 2015 and is looking forward meeting you in Montpellier-France (November 26-27 2015), to discuss your current and future projects involving medicinal chemistry and custom synthesis. Request a meeting at contact@oxeltis.com or (...)
Oxeltis will be at Bio Japan (Yokohama, October 14-16, 2015). We will be happy to meet you to discuss your current and future projects involving: - medicinal chemistry (Hit selection & optimization, SAR analysis, Hit-to-lead (...)
Oxeltis team would be happy to meet you at the Nordic Life Science Days in Stockholm (September 8-19, 2015) and discuss your current and future projects involving medicinal chemistry or (...)
Oxeltis is pleased to sponsor the Gordon Research Conferences on Nucleosides, Nucleotides & Oligonucleotides (June 28 – July 3, 2015) in Salve Regina University, Newport-RI, USA.